Cargando…

RUNX1 Mutations in Inherited and Sporadic Leukemia

RUNX1 is a recurrently mutated gene in sporadic myelodysplastic syndrome and leukemia. Inherited mutations in RUNX1 cause familial platelet disorder with predisposition to acute myeloid leukemia (FPD/AML). In sporadic AML, mutations in RUNX1 are usually secondary events, whereas in FPD/AML they are...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellissimo, Dana C., Speck, Nancy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742424/
https://www.ncbi.nlm.nih.gov/pubmed/29326930
http://dx.doi.org/10.3389/fcell.2017.00111
_version_ 1783288372790296576
author Bellissimo, Dana C.
Speck, Nancy A.
author_facet Bellissimo, Dana C.
Speck, Nancy A.
author_sort Bellissimo, Dana C.
collection PubMed
description RUNX1 is a recurrently mutated gene in sporadic myelodysplastic syndrome and leukemia. Inherited mutations in RUNX1 cause familial platelet disorder with predisposition to acute myeloid leukemia (FPD/AML). In sporadic AML, mutations in RUNX1 are usually secondary events, whereas in FPD/AML they are initiating events. Here we will describe mutations in RUNX1 in sporadic AML and in FPD/AML, discuss the mechanisms by which inherited mutations in RUNX1 could elevate the risk of AML in FPD/AML individuals, and speculate on why mutations in RUNX1 are rarely, if ever, the first event in sporadic AML.
format Online
Article
Text
id pubmed-5742424
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-57424242018-01-11 RUNX1 Mutations in Inherited and Sporadic Leukemia Bellissimo, Dana C. Speck, Nancy A. Front Cell Dev Biol Cell and Developmental Biology RUNX1 is a recurrently mutated gene in sporadic myelodysplastic syndrome and leukemia. Inherited mutations in RUNX1 cause familial platelet disorder with predisposition to acute myeloid leukemia (FPD/AML). In sporadic AML, mutations in RUNX1 are usually secondary events, whereas in FPD/AML they are initiating events. Here we will describe mutations in RUNX1 in sporadic AML and in FPD/AML, discuss the mechanisms by which inherited mutations in RUNX1 could elevate the risk of AML in FPD/AML individuals, and speculate on why mutations in RUNX1 are rarely, if ever, the first event in sporadic AML. Frontiers Media S.A. 2017-12-20 /pmc/articles/PMC5742424/ /pubmed/29326930 http://dx.doi.org/10.3389/fcell.2017.00111 Text en Copyright © 2017 Bellissimo and Speck. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Bellissimo, Dana C.
Speck, Nancy A.
RUNX1 Mutations in Inherited and Sporadic Leukemia
title RUNX1 Mutations in Inherited and Sporadic Leukemia
title_full RUNX1 Mutations in Inherited and Sporadic Leukemia
title_fullStr RUNX1 Mutations in Inherited and Sporadic Leukemia
title_full_unstemmed RUNX1 Mutations in Inherited and Sporadic Leukemia
title_short RUNX1 Mutations in Inherited and Sporadic Leukemia
title_sort runx1 mutations in inherited and sporadic leukemia
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742424/
https://www.ncbi.nlm.nih.gov/pubmed/29326930
http://dx.doi.org/10.3389/fcell.2017.00111
work_keys_str_mv AT bellissimodanac runx1mutationsininheritedandsporadicleukemia
AT specknancya runx1mutationsininheritedandsporadicleukemia